Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 3-arm Phase III Study of 5LGr, Tiapride or Placebo in Pediatric Patients With Tic Disorder

NCT01501695 is registered in ClinicalTrials.gov with Tasly Pharmaceuticals, Inc. as lead sponsor.

NCT NCT01501695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01501695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 3-arm Phase III Study of 5LGr, Tiapride or Placebo in Pediatric Patients With Tic Disorder
Lead sponsor
Tasly Pharmaceuticals, Inc.
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2008
Completion date
October 31, 2011
Enrollment
603 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic tic disorder, tic disorder, tourette syndrome